Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Rosiglitazone maleate (substance) |
Is a |
True |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pioglitazone hydrochloride |
Is a |
True |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thiazolidinedione (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing pioglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Troglitazone |
Is a |
True |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rosiglitazone (substance) |
Is a |
True |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pioglitazone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing metformin and pioglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glimepiride and pioglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pioglitazone (substance) |
Is a |
True |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to thiazolidinedione (finding) |
Causative agent (attribute) |
False |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to thiazolidinedione (finding) |
Causative agent (attribute) |
True |
Thiazolidinedione (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |